Alvimopan, a Peripherally Acting μ-Opioid Receptor Antagonist, is Associated with Reduced Costs after Radical Cystectomy: Economic Analysis of a Phase 4 Randomized, Controlled Trial
Titel:
Alvimopan, a Peripherally Acting μ-Opioid Receptor Antagonist, is Associated with Reduced Costs after Radical Cystectomy: Economic Analysis of a Phase 4 Randomized, Controlled Trial
Auteur:
Kauf, Teresa L. Svatek, Robert S. Amiel, Gilad Beard, Timothy L. Chang, Sam S. Fergany, Amr Karnes, R. Jeffrey Koch, Michael O'Hara, Jerome Lee, Cheryl T. Sexton, Wade J. Slaton, Joel W. Steinberg, Gary D. Wilson, Shandra S. Techner, Lee Martin, Carolyn Moreno, Jessica Kamat, Ashish M.
Verschenen in:
The journal of urology
Paginering:
Jaargang 191 (2014) nr. 6 pagina's 7 p.
Jaar:
2014
Inhoud:
Uitgever:
American Urological Association Education and Research, Inc.